Genetic cooperativity in multi-layer networks implicates cell survival and senescence in the striatum of Huntington’s disease mice synchronous to symptoms

Abstract Motivation Huntington’s disease (HD) may evolve through gene deregulation. However, the impact of gene deregulation on the dynamics of genetic cooperativity in HD remains poorly understood. Here, we built a multi-layer network model of temporal dynamics of genetic cooperativity in the brain of HD knock-in mice (allelic series of Hdh mice). To enhance biological precision and gene prioritization, we integrated three complementary families of source networks, all inferred from the same RNA-seq time series data in Hdh mice, into weighted-edge networks where an edge recapitulates path-length variation across source-networks and age-points. Results Weighted edge networks identify two consecutive waves of tight genetic cooperativity enriched in deregulated genes (critical phases), pre-symptomatically in the cortex, implicating neurotransmission, and symptomatically in the striatum, implicating cell survival (e.g. Hipk4) intertwined with cell proliferation (e.g. Scn4b) and cellular senescence (e.g. Cdkn2a products) responses. Top striatal weighted edges are enriched in modulators of defective behavior in invertebrate models of HD pathogenesis, validating their relevance to neuronal dysfunction in vivo. Collectively, these findings reveal highly dynamic temporal features of genetic cooperativity in the brain of Hdh mice where a 2-step logic highlights the importance of cellular maintenance and senescence in the striatum of symptomatic mice, providing highly prioritized targets. Availability and implementation Weighted edge network analysis (WENA) data and source codes for performing spectral decomposition of the signal (SDS) and WENA analysis, both written using Python, are available at http://www.broca.inserm.fr/HD-WENA/. Supplementary information Supplementary data are available at Bioinformatics online.

[1]  Georgia Woods,et al.  Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson ’ s Disease Graphical , 2018 .

[2]  N. Musi,et al.  Tau protein aggregation is associated with cellular senescence in the brain , 2018, Aging cell.

[3]  K. Masuda,et al.  Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome , 2016, International journal of molecular sciences.

[4]  A. Singleton,et al.  A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s disease , 2017, PloS one.

[5]  Jean-Philippe Vert,et al.  Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons , 2012, BMC Genomics.

[6]  X. Estivill,et al.  Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. , 2016, The Journal of clinical investigation.

[7]  Jean-Philippe Vert,et al.  The Wnt Receptor Ryk Reduces Neuronal and Cell Survival Capacity by Repressing FOXO Activity During the Early Phases of Mutant Huntingtin Pathogenicity , 2014, PLoS biology.

[8]  J. Pintor,et al.  Ectonucleotide pyrophosphatase/phosphodiesterase activity in Neuro‐2a neuroblastoma cells: changes in expression associated with neuronal differentiation , 2014, Journal of neurochemistry.

[9]  Shu-Bing Qian,et al.  A novel FADS1 isoform potentiates FADS2-mediated production of eicosanoid precursor fatty acids , 2012, Journal of Lipid Research.

[10]  E. Huang,et al.  Homeodomain Interacting Protein Kinase 2 Regulates Postnatal Development of Enteric Dopaminergic Neurons and Glia via BMP Signaling , 2011, The Journal of Neuroscience.

[11]  M. Bennett,et al.  Interaction between connexin35 and zonula occludens-1 and its potential role in the regulation of electrical synapses , 2008, Proceedings of the National Academy of Sciences.

[12]  V. Gallo,et al.  A functional role for EGFR signaling in myelination and remyelination , 2007, Nature Neuroscience.

[13]  James J. Pekar,et al.  Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease , 2012, Neuroscience Letters.

[14]  Shuping Zhang,et al.  MGARP Regulates Mouse Neocortical Development via Mitochondrial Positioning , 2013, Molecular Neurobiology.

[15]  S. Mooney,et al.  Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington’s Disease Neural Stem Cells , 2015, Stem cell reports.

[16]  Shannon L. Risacher,et al.  Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data , 2017, Briefings Bioinform..

[17]  Stefano Gustincich,et al.  Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin , 2011, Proceedings of the National Academy of Sciences.

[18]  S. Luo,et al.  Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models , 2017, Cell Research.

[19]  É. Fino,et al.  Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington's Disease. , 2018, Cell reports.

[20]  Emmanuel Barillot,et al.  Classification of microarray data using gene networks , 2007, BMC Bioinformatics.

[21]  Edwin R. Chapman,et al.  Doc2 Is a Ca2+ Sensor Required for Asynchronous Neurotransmitter Release , 2011, Cell.

[22]  A. Reiner,et al.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice , 2013, Neurobiology of Disease.

[23]  Christian Néri,et al.  Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons , 2005, Nature Genetics.

[24]  Jörg Vervoorts,et al.  The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility , 2008, The Journal of cell biology.

[25]  Hyojin Kim,et al.  MouseNet v2: a database of gene networks for studying the laboratory mouse and eight other model vertebrates , 2015, Nucleic Acids Res..

[26]  Elena Cattaneo,et al.  Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.

[27]  A. Moreau,et al.  SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer , 2016, Nature Communications.

[28]  Takuma Hayashi,et al.  Physiological significance of recombination‐activating gene 1 in neuronal death, especially optic neuropathy , 2015, The FEBS journal.

[29]  Zhandong Liu,et al.  High-Throughput Functional Analysis Distinguishes Pathogenic, Nonpathogenic, and Compensatory Transcriptional Changes in Neurodegeneration. , 2018, Cell systems.

[30]  X. W. Yang,et al.  Molecular insights into cortico-striatal miscommunications in Huntington's disease , 2018, Current Opinion in Neurobiology.

[31]  Nataša Pržulj,et al.  Methods for biological data integration: perspectives and challenges , 2015, Journal of The Royal Society Interface.

[32]  M. Yoder,et al.  PRL2/PTP4A2 Phosphatase Is Important for Hematopoietic Stem Cell Self‐Renewal , 2014, Stem cells.

[33]  C. Néri,et al.  Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice. , 2015, Human molecular genetics.

[34]  Giovanni Coppola,et al.  Integrated genomics and proteomics to define huntingtin CAG length-dependent networks in HD Mice , 2016, Nature Neuroscience.

[35]  D. Baker,et al.  Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline , 2018, Nature.

[36]  R. Morimoto,et al.  Huntington's disease: underlying molecular mechanisms and emerging concepts. , 2013, Trends in biochemical sciences.

[37]  Joseph R. Scarpa,et al.  Systems Genetic Analyses Highlight a TGFβ-FOXO3 Dependent Striatal Astrocyte Network Conserved across Species and Associated with Stress, Sleep, and Huntington’s Disease , 2016, PLoS genetics.

[38]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[39]  M. MacDonald,et al.  Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice , 2016, Nature Biotechnology.